AZD7594
Sponsors
AstraZeneca
Conditions
AsthmaChronic Obstructive Pulmonary Disease (COPD)Pharmacodynamics of AZD7594PharmacokineticsSafety
Phase 1
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594
CompletedNCT01636024
Start: 2012-09-30End: 2013-06-30Updated: 2013-06-20
A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants
CompletedNCT02967159
Start: 2016-11-24End: 2017-04-06Updated: 2018-02-13
A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
CompletedNCT03976869
Start: 2019-07-24End: 2020-07-09Updated: 2021-01-29
A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.
CompletedNCT04072562
Start: 2019-09-19End: 2019-11-28Updated: 2019-12-16